R
Market Data
$42.55+$11.64 (+37.66%)
RIGL · Last trade
Prev Close
$30.91
Range (29d)
$32.08 – $43.76
Recent Filings
- 8-K138.2 KBRIGEL PHARMACEUTICALS INCJul 1, 4:11 PM ET·0001034842-26-000045
- 8-K138.0 KBRIGEL PHARMACEUTICALS INCJun 17, 4:05 PM ET·0001034842-26-000043
- 8-K168.4 KBRIGEL PHARMACEUTICALS INCMay 20, 4:10 PM ET·0001034842-26-000041
- 8-K143.0 KBRIGEL PHARMACEUTICALS INCMay 12, 5:24 PM ET·0001034842-26-000038
- 8-K261.6 KBRIGEL PHARMACEUTICALS INCMay 5, 4:08 PM ET·0001034842-26-000033
- 10-Q7.0 MBRIGEL PHARMACEUTICALS INCMay 5, 4:05 PM ET·0001034842-26-000032
- 8-K139.7 KBRIGEL PHARMACEUTICALS INCApr 21, 4:18 PM ET·0001034842-26-000027
- 8-K299.4 KBRIGEL PHARMACEUTICALS INCMar 3, 4:11 PM ET·0001034842-26-000016
- 10-K11.7 MBRIGEL PHARMACEUTICALS INCMar 3, 4:06 PM ET·0001034842-26-000015
- 8-K140.9 KBRIGEL PHARMACEUTICALS INCFeb 3, 4:01 PM ET·0001034842-26-000007
Insiders
10- ALTA BIOPHARMA PARTNERS II LP10% Owner
- ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC10% Owner
- Ali-Jackson KamilDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- CHAMPSI FARAHSee footnotes
- Cabatuan NelsonPrincipal Accounting Officer
- DEERFIELD INTERNATIONAL LTD10% Owner, Possible Members of 10% Group
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Members of 10% Group
Tickers
Addresses
business
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA, 94080
mailing
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- RIGEL PHARMACEUTICALS INC2026-07-01